White label – Pompe disease - ClinicalTrials.eu

A Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma

Recruiting

3 1 1 1
Investigated Diseases:
- Malignant melanoma
Investigated Drugs:
- Nivolumab
+1
A Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department

Recruiting

3 1 1
Investigated Drugs:
A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

Recruiting

3 1 1 1
Investigated Diseases:
- Neovascular age-related macular degeneration
Investigated Drugs:
- ZUNIBERGENE ROCPARVOVEC
- Aflibercept
+3
Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

Recruiting

2 1 1 1
Investigated Drugs:
Study of ALE.

Recruiting

2 1 1
Investigated Drugs:
- ALE.P03
A Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back

Recruiting

2 1 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
- Atezolizumab
- Bevacizumab
Long-Term Safety Study of Direclidine in Adults with Schizophrenia

Recruiting

3 1 1
Investigated Diseases:
- Schizophrenia
A Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST PD-L1 CONJUGATED TO MONOMETHYL AURISTATIN E VIA A VALINE-CITRULLINE LINKER
- Docetaxel
+8
A Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Abemaciclib
- Giredestrant
Study of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome

Recruiting

2 1
Investigated Drugs:
- 1-((3S,8S,9S,10R,13S,14S,17S)3-BENZYLOXY-10,13,17-TRIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1HCYCLOPENTA[A]PHENANTHRENE-17-YL)ETHAN-1-ONE

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies